Search company, investor...

Predict your next investment

Asset/Investment Management
valiance-am.com

Investments

15

Portfolio Exits

3

About Valiance Asset Management

Valiance is a specialist investment business with offices in London and Guernsey, authorised and regulated by the UK Financial Services Authority and Guernsey Financial Services Commission. Valiance has built a one stop asset management platform with multiple investment pillars where a close network of clients, including sovereign wealth funds, leading families, private banks, endowments, pension funds and other institutional investors find reliable, transparent access to a variety of (co)-investment opportunities.

Headquarters Location

13 Hanover Square

London, England, W1S 1HN,

United Kingdom

+44 (0)20 7399 1760

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Valiance Asset Management News

MDxHealth Shareholder Transparency Declaration

Apr 7, 2023

APRIL 7, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – April 7, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of May 2, 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions (the "Belgian Transparency Act"), that it received the following notification. The Company was notified that the number of shares with respect to which Valiance Asset Management Limited can exercise voting rights passively crossed below the threshold of 10% of the outstanding shares and voting rights of mdxhealth on February 7, 2023. Notably, it follows from the notification by Valiance Asset Management Limited, who notified alone, that an aggregate of 20,931,094 shares of mdxhealth, representing 7.96% of the 262,880,936 outstanding shares and voting rights of mdxhealth, is held through the following entities: Valiance Holdings Limited, being a Guernsey company within the Valiance corporate structure; Valiance Life Sciences Growth Investment Fund SICAV-SIF, being a Luxembourg fund with multiple external investors; and TopMDx Ltd, being an exempted closed-ended fund registered in British Virgin Islands with multiple external investors. The notification also stated that the investment manager, Valiance Asset Management Limited, which is not a controlled entity, can exercise the voting rights at its discretion for each of these 3 entities. For further information, reference is made to the information published on mdxhealth's website ( http://www.mdxhealth.com/investors/shareholder-information ). Pursuant to the Belgian Transparency Act and the articles of association of the Company, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company. About mdxhealth® mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands. For more information, visit mdxhealth .com and follow us on social media at: twitter.com/mdxhealth , facebook.com/mdxhealth and linkedin.com/company/mdxhealth . For more information:

Valiance Asset Management Investments

15 Investments

Valiance Asset Management has made 15 investments. Their latest investment was in JenaValve as part of their Series H on September 01, 2022.

CBI Logo

Valiance Asset Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/1/2022

Series H

JenaValve

$100M

No

5

2/5/2020

Series G

JenaValve

$50M

No

15

10/24/2019

Series C - II

Laminate Medical Technologies

Yes

1

5/14/2019

Series B

Subscribe to see more

$99M

Subscribe to see more

10

3/7/2018

Unattributed - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/1/2022

2/5/2020

10/24/2019

5/14/2019

3/7/2018

Round

Series H

Series G

Series C - II

Series B

Unattributed - II

Company

JenaValve

JenaValve

Laminate Medical Technologies

Subscribe to see more

Subscribe to see more

Amount

$100M

$50M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

15

1

10

10

Valiance Asset Management Portfolio Exits

3 Portfolio Exits

Valiance Asset Management has 3 portfolio exits. Their latest portfolio exit was Neosync on February 26, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/26/2020

Asset Sale

$99M

1

3/5/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/27/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/26/2020

3/5/2019

4/27/2015

Exit

Asset Sale

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Valiance Asset Management Team

2 Team Members

Valiance Asset Management has 2 team members, including current Founder, Managing Partner, Jan Pensaert.

Name

Work History

Title

Status

Jan Pensaert

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Jan Pensaert

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Status

Current

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.